Dalbavancin
Product Description
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Employees:1000 - 4999
Company types
Specifications
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Employees:1000 - 4999
Company types
More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)
-
Product Trabectedin
• Status: Validated • Patent Expiration: ODE：2022.10.23；NCE：2020.10.23 • Usage: Oncology -
Product Alvimopan
• Status: Pre-validation • Patent Expiration: US：2022.11 • Usage: Intestinal Ostruction -
Product Posaconazole(Form Ⅰ)
• Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal -
Product Posaconazole(Form Ⅲ)
• Status: DMF No.:030886 • Patent Expiration: Off-patent • Usage: Antifungal -
Product Sugammadex Sodium
• Status: DMF No. :033904 • Patent Expiration: US：2021.01.27； CN：2020.11.23 • Usage:Selective relaxant binding agent -
Product Tenofovir alafenamide,TAF
• Status: Validated • Patent Expiration: CN：2021.7；US：2032.8 • Usage: AntiHBV -
Product Oseltamivir phosphate
• Status: Validated and DMF ready • Patent Expiration: Off-patent • Usage: Anti-infection -
Product Doramectin
• Status: Commercial • Patent Expiration: Off-patent • Usage: Veterinary -
Product Eldecalcitol
• Status: Pre-validation • Patent Expiration: Off-patent • Usage: Osteoporosis -
Product Emodepside
• Status: Pilot • Patent Expiration: Off-patent • Usage: Veterinary -
Product Ferric carboxymaltose
• Status: Pre-validation, PV will be done in Oct • Patent Expiration: US：2027.03.04; • Usage: Iron Supplement -
Product Ferric citrate hydrate
• Status: Pilot • Patent Expiration: Off-patent • Usage: Iron Supplement